Mounjaro 2 pens: what happens when your treatment moves to a second pen

You've used pen one. Here's what pen two is likely to bring.

Picture this: you've just administered your fourth and final injection from your first Mounjaro pen. The needle is capped, the pen goes into a sharps container rather than the bin, and you're about to start pen two. For many people, this is the moment the question arises, is this pen the same strength as the last one, or has something changed?

The answer depends on your prescriber's assessment. Mounjaro is available in six UK strengths: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Treatment begins at 2.5 mg, a dose that exists to help your system adjust rather than to produce the full therapeutic effect. After four weeks, a prescriber typically considers whether to increase the dose. So if your first pen was 2.5 mg, your second is often 5 mg, but only once a clinician has confirmed you're ready. That step is made on clinical grounds, not automatically.

One misconception worth letting go gently: people sometimes assume the second pen is simply a repeat of the first, like a refill. It often isn't. The dose schedule is personalised, and two patients who started treatment the same day may be on different strengths by week eight depending on how their bodies responded and how well they tolerated titration. Your prescriber reviews that individually. The Mounjaro injection pen itself works the same way regardless of dose, the mechanism is identical; the concentration is what differs.

The clinical check that sits between pen one and pen two

Getting a second pen isn't as simple as reordering. A clinical review is the step that links one pen to the next, particularly when a dose change is involved. At nume, a GPhC-registered Independent Prescriber reads every repeat request personally, a real clinician reviews your submission the same day, not software working through a checklist.

What does that review look at? Broadly: how much weight you've lost so far, any side effects you've experienced, and whether you're tolerating your current dose well enough to move up. The Mounjaro treatment overview sets out the licensed eligibility criteria and how private assessment works if you're not on an NHS pathway. Worth reading before your repeat if you have questions about what comes next.

For patients transferring from another provider and requesting a higher dose, evidence of your current dose is required, this is a patient-safety measure, not a bureaucratic hurdle. A prescriber needs to know where you actually are in the titration schedule before authorising pen two at an increased strength. The detail on how the pen works can help you understand what information is useful to have ready.

NHS guidance on weight-management injections confirms that titration should be guided by clinical assessment at each step, not run on a fixed automatic timetable. NHS England's guidance on weight-management injections makes clear that ongoing clinical involvement is part of safe treatment, not optional extra care.

Injection technique with pen two: the things worth revisiting

By the time you reach pen two, injection technique has usually settled into routine, and that's mostly a good thing. Confidence grows. But familiarity can occasionally bring small habits that are worth checking. The injection site is one of them.

The abdomen, outer thigh and upper arm are all suitable sites for Mounjaro. The guidance is to rotate, not just between body areas but within them, moving a few centimetres from the previous spot each week. Using the same patch of skin repeatedly can cause localised reactions: mild lumps, tenderness or thickening. Rotating properly reduces that risk. If you're using alcohol swabs to clean the site beforehand, let the skin dry fully before injecting to avoid a brief stinging sensation.

Needles are a separate consideration. Each injection uses one needle, and that needle should be changed for every dose, reusing needles between injections increases the risk of injection-site discomfort and affects the accuracy of delivery. The guidance on needles for Mounjaro pens covers compatibility and what to look for. Storage for the new pen matters too: if you want a full picture of how the devices are designed and what to expect when you open a fresh one, the overview of Mounjaro pens is a useful reference before you begin, then follow the Patient Information Leaflet for the room-temperature window, that window is time-limited and the leaflet gives the precise figure.

Side effects with pen two are worth monitoring, especially if the dose has increased. Nausea, loose stools, indigestion and fatigue are the most commonly reported; they tend to be most noticeable in the first few days after a dose change and often ease within two weeks. Severe or persistent stomach pain that reaches through to the back needs prompt medical attention. The NHS tirzepatide page lists symptoms that warrant contacting a doctor.

What the cost of a second pen looks like in context

Cost is a practical question and a fair one. Pen two carries the same per-pen price as pen one at the same strength; if you've moved to a higher dose, the price reflects that dose. For an honest picture of how Mounjaro private pricing works (including what changed after Eli Lilly's September 2025 list-price revision) the Mounjaro cost page covers the current market context without glossing over the numbers.

At nume, treatment is priced as a single transparent amount that includes the clinical review, the prescription, the pen and next-working-day tracked delivery. No subscription is attached, each repeat order is reviewed fresh. That matters for pen two specifically: you're not locked in, and the prescriber re-evaluates your case each time rather than processing a standing order.

Ready to discuss where you are in your treatment? Start your free consultation and a prescriber will review your case the same day.